Search

Home > Diabetes Discourse > How Similar are Biosimilar Insulins?
Podcast: Diabetes Discourse
Episode:

How Similar are Biosimilar Insulins?
Category: Science & Medicine
Duration: 00:00:00
Publish Date: 2011-05-25 13:28:50
Description: Host: Steven Edelman, MD
Guest: Lutz Heinemann, PhD
Biosimilar insulin is an attractive market to a number of American and European pharmaceutical companies. Biosimilar insulin manufacture is complicated for a number of reasons. Guest host Dr. Timothy Bailey talks with Dr. Lutz Heinemann, director of scientific services at Profil Institute for Clinical Research in San Diego and headquartered in Neuss, Germany, about the challenges and guidelines around producing safe and effective biosimilars. And, for healthcare providers, what are the practical aspects of switching to a biosimilar insulin?
Total Play: 0

Some more Podcasts by ReachMD

200+ Episodes
Primary Care .. 50+     6
200+ Episodes
Focus on Neu .. 10+     3